Illustration: Sarah Grillo/Axios

While the abuse of prescription opioids has received widespread attention, benzodiazepine (BZD) sedatives have seen a similar growth rate, with prescription rates nearly doubling since 2003.

Why it matters: In the U.S., deaths associated with BZDs like Xanax and Valium have increased from 135 in 1999 to over 11,500 in 2017. The dangers of misusing these potentially addictive drugs are particularly acute for adults over 50, who have experienced the largest increase in BZD prescriptions.

What's happening: The increase in deaths and overdoses associated with BZDs has been driven by misuse. Although BZDs are intended to be used for less than 14 days, chronic use — over 120 days — is common.

What's needed:

What to watch: Policymakers are beginning to recognize the harmful side effects of BZDs and other hypnotics. Policy reform — coupled with prescriber accountability and provider and patient education — could mitigate dangerous trends of misuse.

Nambi J. Ndugga and Elsa Pearson are policy analysts at the Boston University School of Public Health (BUSPH). Melissa Garrido is the associate director of the Partnered Evidence-Based Policy Resource Center at the Veterans Health Administration and a research associate professor at BUSPH.

Go deeper

4 mins ago - Technology

Tech hits the brakes on office reopenings

Illustration: Annelise Capossela/Axios

Tech was the first industry to send its workers home when COVID-19 first hit the U.S., and it has been among the most cautious in bringing workers back. Even still, many companies are realizing that their reopening plans from as recently as a few weeks ago are now too optimistic.

Why it matters: Crafting reopening plans gave tech firms a chance to bolster their leadership and model the beginnings of a path back to normalcy for other office workers. Their decision to pause those plans is the latest sign that normalcy is likely to remain elusive in the U.S.

The existential threat to small business

Illustration: Eniola Odetunde/Axios

The coronavirus pandemic has changed the game for U.S. businesses, pushing forward years-long shifts in workplaces, technology and buying habits and forcing small businesses to fight just to survive.

Why it matters: These changes are providing an almost insurmountable advantage to big companies, which are positioned to come out of the recession stronger and with greater market share than ever.

Students say they'll sacrifice fun if they can return to campus

Illustration: Aïda Amer/Axios

College students overwhelmingly plan to return to campus this fall if their schools are open — and they claim they'll sit out the fun even if it's available, according to a new College Reaction/Axios poll.

Why it matters: For many, even an experience devoid of the trappings of college life is still a lot better than the alternative.